SEC 13F Intelligence

Fayez Sarofim & Co / JNJ

Fayez Sarofim & Co’s Johnson & Johnson Position

Does Fayez Sarofim & Co own Johnson & Johnson (JNJ)? Yes — 651.3K shares worth $159M (+0.41% of its 13F portfolio) as of Q1 2026, down from 659.1K shares the prior filed quarter.

Position Value
$159M
Q1 2026
Shares
651.3K
% of Portfolio
+0.41%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $277MQ4 ’18Q1 ’19: $304MQ2 ’19: $290MQ3 ’19: $269MQ4 ’19: $304MQ4 ’19Q1 ’20: $259MQ2 ’20: $299MQ3 ’20: $315MQ4 ’20: $330MQ4 ’20Q1 ’21: $342MQ2 ’21: $340MQ3 ’21: $332MQ4 ’21: $362MQ4 ’21Q1 ’22: $399MQ2 ’22: $427MQ3 ’22: $393MQ4 ’22: $421MQ4 ’22Q1 ’23: $316MQ2 ’23: $282MQ3 ’23: $202MQ4 ’23: $163MQ4 ’23Q1 ’24: $154MQ2 ’24: $133MQ3 ’24: $146MQ4 ’24: $131MQ4 ’24Q1 ’25: $146MQ2 ’25: $129MQ3 ’25: $155MQ4 ’25: $136MQ4 ’25Q1 ’26: $159Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026651.3K$159M+0.41%
Q4 2025659.1K$136M+0.33%
Q3 2025837.0K$155M+0.36%
Q2 2025842.8K$129M+0.31%
Q1 2025878.7K$146M+0.36%
Q4 2024903.5K$131M+0.32%
Q3 2024903.1K$146M+0.37%
Q2 2024906.8K$133M+0.36%
Q1 2024974.9K$154M+0.46%
Q4 20231.04M$163M+0.50%
Q3 20231.30M$202M+0.68%
Q2 20231.70M$282M+0.99%
Q1 20232.04M$316M+1.10%
Q4 20222.38M$421M+1.56%
Q3 20222.41M$393M+1.55%
Q2 20222.41M$427M+1.56%
Q1 20222.25M$399M+1.26%
Q4 20212.12M$362M+1.09%
Q3 20212.06M$332M+1.10%
Q2 20212.06M$340M+1.14%
Q1 20212.08M$342M+1.26%
Q4 20202.10M$330M+1.27%
Q3 20202.12M$315M+1.35%
Q2 20202.13M$299M+1.38%
Q1 20201.97M$259M+1.59%
Q4 20192.08M$304M+1.46%
Q3 20192.08M$269M+1.39%
Q2 20192.08M$290M+1.50%
Q1 20192.17M$304M+1.60%
Q4 20182.15M$277M+1.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fayez Sarofim & Co’s full portfolio or all institutional holders of JNJ.